Helicobacter pylori therapy in children: overview and challenges

International Journal of Immunopathology and Pharmacology
C ChiesaJ F Osborn

Abstract

Helicobacter pylori is one of the most common infections found in humans. It was first identified in 1982 and by 1989 had been associated with gastric inflammation and ulcers in adults and children. During the 1990's evidence emerged of its etiologic role in stomach cancers in adults. That the infection is common and may have serious consequences, has led to an avalanche of research during the last twenty years. During this time, there have been many studies on children which have sought an effective and safe treatment to eradicate the infection, but as yet, no therapy regimen has been found which is always effective and safe. This article provides information, from a pediatric point of view, on the major developments in the therapeutics and therapy of H. pylori infection. It examines first-line treatment regimens, evaluates the efficacy of the main drugs used in the management of (primary) H. pylori infection in children, assesses the potential for the use of probiotics and sequential therapy, examines therapeutic options after failure of initial treatment, and discusses factors affecting eradication rate, including antibiotic resistance, adherence to therapy, and bacterial factors.

References

Apr 1, 1997·Archives of Disease in Childhood·D WalshB Drumm
Oct 21, 1998·Journal of Pediatric Gastroenterology and Nutrition·T H CasswallK A Dahlström
Jan 16, 1999·Journal of Pediatric Gastroenterology and Nutrition·F C HuangC T Shun
Jun 18, 1999·Archives of Disease in Childhood·R BehrensM Stolte
Apr 5, 2000·Journal of Pediatric Gastroenterology and Nutrition·H ShashidharV Tolia
Jan 6, 2001·Journal of Pediatric Gastroenterology and Nutrition·B D GoldUNKNOWN North American Society for Pediatric Gastroenterology and Nutrition
Jun 16, 2001·Antimicrobial Agents and Chemotherapy·N KalachJ Raymond
Jun 29, 2001·Journal of Pediatric Gastroenterology and Nutrition·N KoçakF Gürakan
Jul 27, 2001·The Journal of International Medical Research·P L ShcherbakovY B Belousov
Feb 22, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Nicolas KalachChrisophe Dupont
Oct 11, 2002·The New England Journal of Medicine·Sebastian Suerbaum, Pierre Michetti
Nov 27, 2004·Journal of Gastroenterology·Seiichi KatoKazuie Iinuma
Apr 30, 2005·Journal of Pediatric Gastroenterology and Nutrition·Joseph FaberMichael Wilschanski
Nov 2, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·Manisha SinghNarendra Krishnani
Apr 12, 2006·European Journal of Gastroenterology & Hepatology·Shahla BahremandShahriar Aghakhani
Aug 1, 2006·Journal of Pediatric Gastroenterology and Nutrition·Tina ArenzSibylle Koletzko
Sep 29, 2006·World Journal of Gastroenterology : WJG·Elisabete KawakamiFrancy Reis Silva Patricio
Feb 21, 2007·Helicobacter·Alexander A NijevitchAlexander G Arsamastsev
Feb 22, 2007·The Journal of Nutrition·Drahoslava Lesbros-PantoflickovaAndré L Blum
Feb 17, 2009·Archivum Immunologiae Et Therapiae Experimentalis·Mitsushige Sugimoto, Yoshio Yamaoka
Apr 17, 2009·World Journal of Gastroenterology : WJG·Vincenzo De FrancescoAngelo Zullo

❮ Previous
Next ❯

Citations

Aug 18, 2012·ISRN Gastroenterology·M GasparettoG Guariso
Mar 13, 2012·Alimentary Pharmacology & Therapeutics·L PacificoC Chiesa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Related Papers

Current Opinion in Rheumatology
P E Phillips
Current Infectious Disease Reports
Jonathan A SilversidesAndrew J Ferguson
Human Vaccines & Immunotherapeutics
Mohan BairwaKapil Yadav
© 2021 Meta ULC. All rights reserved